Skip to content

Standardized research and clinical efficacy evaluation of treatment of interstitial lung disease based on lung-collateral theory

Standardized research and clinical efficacy evaluation of treatment of interstitial lung disease based on lung-collateral theory

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003785
Enrollment
Unknown
Registered
2020-08-27
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial lung disease

Interventions

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the western medicine diagnosis of the disease; 2. Meet the TCM diagnosis and syndrome differentiation standards of this disease; 3. The patient voluntarily accepted the treatment and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Age> 80 years old; 2. Combined with tuberculosis, fungus, tumor, etc. and other primary lung diseases; 3. Patients with severe complications of other diseases such as cardiovascular, urinary, digestive, hematopoietic, endocrine and metabolic systems, liver and kidney insufficiency, and mental illness; 4. Pregnant or lactating women and those who are known to be allergic to the components of this medicine; 5. Those who fail to use the prescribed drugs and follow the doctor's advice, cannot judge the curative effect or whose clinical data is incomplete and affect the judgment; 6. Participating in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
HRCT change point;PaO2;symptom score;lung function;

Secondary

MeasureTime frame
MRC score;the change score of ATAQ-IPF;

Countries

China

Contacts

Public ContactLixin Wang

Shanghai Pulmonary Hospital

wlx1126@hotmail.com+86 18917962300

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026